<unk> is the leading cause of disability worldwide, the United Nations (UN) health agency reported, estimating that it affects more than 300 million people worldwide – the majority of them women, young people and the elderly. An estimated 4.4 percent of the global population suffers from<unk>  according to a report released by the UN World Health Organization (WHO), which shows an 18 percent increase in the number of people living with<unk> between 2005 and 2015.<unk> is a major mental-health cause of disease burden. Its consequences further lead to significant burden in public health, including a higher risk of dementia, premature mortality arising from physical disorders, and maternal<unk> impacts on child growth and development. Approximately 76% to 85% of depressed people in low- and middle-income countries do not receive treatment; barriers to treatment include: inaccurate assessment, lack of trained health-care providers, social stigma and lack of resources. The stigma comes from misguided societal views that people with mental illness are different from everyone else, and they can choose to get better only if they wanted to. Due to this more than half of the people with<unk> do not receive help with their disorders. The stigma leads to a strong preference for privacy. The World Health Organization has constructed guidelines – known as The Mental Health Gap Action Programme (mhGAP) – aiming to increase services for people with mental, neurological and substance-use disorders.<unk> is listed as one of conditions prioritized by the programme. Trials conducted show possibilities for the implementation of the programme in low-resource primary-care settings dependent on primary-care practitioners and lay health-workers. Examples of mhGAP-endorsed therapies targeting<unk> include Group Interpersonal Therapy as group treatment for<unk> and "Thinking Health", which utilizes cognitive behavioral therapy to tackle perinatal<unk>  Furthermore, effective screening in primary care is crucial for the access of treatments. The mhGAP adopted its approach of improving detection rates of<unk> by training general practitioners. However, there is still weak evidence supporting this training.
Depression 
Hypothyroidism
Late life depression
Malaise
Double depression
Autism spectrum  disorder  1
Mood disorder
Retarded depression